Melody Cobleigh
- Oncology top 0.05%
- Molecular Biology top 1%
- Cancer Research top 0.2%
- Radiology, Nuclear Medicine and Imaging top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Co-authors
- Kathy D. MillerDennis J. SlamonDavid CellaLouis FehrenbacherMaura N. DicklerDebu TripathyCharles L. VogelSteven Shak
- Topics
- HER2/EGFR in Cancer Research (49 papers)Cancer Treatment and Pharmacology (39 papers)Breast Cancer Treatment Studies (21 papers)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Melody Cobleigh
128 papers receiving 14.2k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 10.5k
- Molecular Biology 4.3k
- Cancer Research 3.8k
- Radiology, Nuclear Medicine and Imaging 3.0k
- Pulmonary and Respiratory Medicine 2.8k
Countries citing papers authored by Melody Cobleigh
This map shows the geographic impact of Melody Cobleigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melody Cobleigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melody Cobleigh more than expected).
Fields of papers citing papers by Melody Cobleigh
This network shows the impact of papers produced by Melody Cobleigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melody Cobleigh. The network helps show where Melody Cobleigh may publish in the future.
Co-authorship network of co-authors of Melody Cobleigh
This figure shows the co-authorship network connecting the top 25 collaborators of Melody Cobleigh. A scholar is included among the top collaborators of Melody Cobleigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melody Cobleigh. Melody Cobleigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 16 | |
| 4 | 17 | |
| 5 | 23 | |
| 6 | 2 | |
| 7 | 45 | |
| 8 | 63 | |
| 9 | 2 | |
| 10 | 47 | |
| 11 | 45 | |
| 12 | 79 | |
| 13 | 487 | |
| 14 | 342 | |
| 15 | 221 | |
| 16 | Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancerbreakdown → | 1508 |
| 17 | 44 | |
| 18 | Estrogen receptor status in the Herceptin (trastuzumab) clinical trials: Incidence and relation to clinical benefit | 2 |
| 19 | 145 | |
| 20 | 22 |
About Melody Cobleigh
Melody Cobleigh is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 131 papers that have together received 14.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (49 papers), Cancer Treatment and Pharmacology (39 papers) and Breast Cancer Treatment Studies (21 papers). The work is most often cited by research in Oncology (10.5k citations), Cancer Research (3.8k citations) and Radiology, Nuclear Medicine and Imaging (3.0k citations). Melody Cobleigh has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Kathy D. Miller, Dennis J. Slamon, David Cella, Louis Fehrenbacher, Maura N. Dickler, Debu Tripathy, Charles L. Vogel, Steven Shak, Julie R. Gralow and Nancy E. Davidson. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.